Capital One’s history of being data driven and building enterprise platforms accelerates innovation. Leaning on consolidated ...

Using Stacker stories that already meet the bar for high-quality journalism and are optimized for interest and engagement, we’ve seen publishers have success with the right kinds of content and ...

Cardano founder Hoskinson predicts RealFi will drive $1B in TVL by 2026, boosting DeFi adoption and ADA demand.

Bungie gives fans a preview of its planned major exotic weapon buffs coming to Destiny 2 when the Renegades expansion ...

It is certainly possible that today’s bottlenecks will prove to be rather short-lived as companies increasingly learn to ...

B y any measure, there is an enormous number of programming languages. Some lists contain hundreds, while the Historical ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Every application needs authorization. It’s the backbone that decides who can access what, when, and under which conditions. But the hard part isn’t ...

Recursion CEO Chris Gibson is out after 12 years as the ambitious "techbio" company positions itself for its next phase of AI drug discovery.

Recursion Pharmaceuticals Inc. RXRX) on Wednesday reported a loss of $162.3 million in its third quarter. The Salt Lake City-based company said it had a loss of 36 cents per share.

Abstract: One of the major challenges of diagnosing rotor symmetry faults in induction machines (IMs) is severe modulation of fault and supply frequency components. In particular, existing techniques ...